The 20 Best Familial Prostate Cancer Doctors Near Me

Brian T. Helfand, MD, a urologist at Endeavor Health, specializes in urologic oncology and the treatment of prostate conditions. His clinical expertise includes minimally invasive surgery, advanced laparoscopy and procedures using the da Vinci robotic system. Dr. Helfand treats conditions such as benign prostatic hyperplasia, prostate cancer and urinary dysfunction using personalized and evidence-based approaches. Dr. Helfand is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Aquablation, and Prostatectomy.

My goals are to develop and provide treatments that prolong and improve quality of the lives of patients with aggressive prostate, kidney, bladder, and testicular cancer. This work involves the direct care of patients in the clinic and clinical research involving the development of new therapies in clinical trials. I devote over half of my time to understanding how prostate cancer spreads and resists therapies, as well as methods of measuring this biology in patients, which may lead to improved therapies designed to block this process. Outside of work, I have a busy family life with three children, and a wife who is a Duke pediatrician. I enjoy playing soccer and hiking. Dr. Armstrong is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy.

William Catalona is a Urologist in Chicago, Illinois. Dr. Catalona has been practicing medicine for over 58 years and is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bacterial Prostatitis, Prostatectomy, and Vasectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy.

Edward Schaeffer is an Oncologist in Chicago, Illinois. Dr. Schaeffer has been practicing medicine for over 25 years and is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy.

I have a passion for caring for men with prostate cancer and helping them and their families make the best treatment decisions. I am nationally and internationally recognized as a prostate cancer expert and have performed more than 2,000 radical prostatectomies both at Duke and formerly at Walter Reed Army Medical Center. I specialize in the nerve-sparing technique of surgery affording the best chance for sexual recovery. I have more experience with this small incisional open hands-on nerve-sparing operation than any surgeon in the Southeastern United States and am among the 10 most experienced surgeons using this technique in the United States. In addition to surgery, I have extensive experience managing men who have an elevated PSA and perform a gentle prostate biopsy using very liberal doses of local anesthesia. Our team also offers management of men who elect active surveillance for their early stage prostate cancer and are sensitive to men's needs regarding management of temporary urinary and sexual dysfunction related to prostate cancer treatments. We have a very experienced nursing team and a very experienced physician assistant who greatly assists in comprehensive and compassionate care. Dr. Moul is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Orchiectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Daniel Shevrin, MD, a medical oncologist at Endeavor Health, combines advanced cancer knowledge with compassion and personalized care. He helps patients understand complex diagnoses and collaborates on treatment plans that balance effectiveness and quality of life. Dr. Shevrin is actively involved in prostate cancer research, leading a genomics study to guide more precise therapies for men with advanced disease. He sees each patient as a person first and believes empathy is as essential as evidence-based care. Dr. Shevrin is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Hereditary Neuroblastoma, Non-Muscle Invasive Bladder Cancer, and Prostatectomy.

Christopher Schreiber is a Urologist in Sidney, Montana. Dr. Schreiber has been practicing medicine for over 32 years and is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Obstructive Uropathy, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Schreiber is currently accepting new patients.

Richard Vanlangendonck, MD is a urologist at Intermountain Health’s Heber Valley Specialty Clinic in Hever City, Utah, and Jerry & Kathleen Grundhofer Clinic – Urology in Park City, Utah. He supports patients in Park City, Snyderville, Kamas, Francis, Woodland, Heber City, and surrounding communities, treating prostate cancer, kidney cancer, adrenal cancer, bladder cancer, and more. His clinical interests focus on robotic surgery for the treatment of prostate and kidney cancer. He is passionate about this technology's advanced capabilities, allowing for precise and minimally invasive procedures that significantly benefit his patients. Dr. Vanlangendonck is deeply committed to providing his patients with the highest standard of care. Guided by his philosophy of being the best doctor and person he can be, he treats each individual with compassion and respect. Committed to excellence, the Louisiana native continually strives to perfect his craft. He takes great pride in delivering outstanding patient care and ensuring that each patient is satisfied.Potential patients should know that Dr. Vanlangendonck excels in his field and is passionate about his expertise. He brings this expertise to his practice every day, providing his patients with the highest level of care and support throughout their wellness journey.Conditions Treated: Prostate CancerKidney CancerAdrenal CancerBladder CancerKidney and Ureteral StonesBenign Prostatic Hyperplasia Elevated PSAVoiding Dysfunction Erectile DysfunctionProcedures Performed: Robotic Urologic Surgery for Urologic Cancers Robotic Urologic Surgery for Urinary Obstruction Ureteroscopy Transurethral Surgery for Bening and Malignant DiseaseCystoscopyTransrectal and Transperineal Ultrasound with Prostate BiopsyVasectomy. Dr. Vanlangendonck is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Reconstructive Urology Surgery, and Nephrectomy.

. Dr. Bermejo is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Alex Zacharias is a Urologist in Milwaukee, Wisconsin. Dr. Zacharias is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Reconstructive Urology Surgery, and Ureteroscopy.

Aaron Sulman is a Urologist in Menomonee Falls, Wisconsin. Dr. Sulman is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Kidney Stones, Vasectomy, and Ureteroscopy.

. Dr. Carter is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), UPJ Obstruction, Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy.

Steven Weiner is a Urologist in Elkhorn, Wisconsin. Dr. Weiner is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Urinary Tract Infection in Children, UPJ Obstruction, Familial Prostate Cancer, Ureteroscopy, and Prostatectomy.

. Dr. Korytko is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Throat Cancer, and Lung Adenocarcinoma.

"Dr. Grant Taylor has been practicing urology in the Tri-Cities area since 2005. He says, ""We love the people in this area and the beauty around us. We enjoy outdoor activities, and this area affords us many opportunities to get outside."" Dr. Taylor's personal philosophy for treating patients is, ""Listen first and understand why they are here seeing us and the impact this issue has on them. This allows us to have aligned goals for their care."" He says, ""We all have difficult days in our lives. This is a sacred space that we as physicians are in with our patients, and we have the privilege of walking that with them and providing the kind of care we would want for our family.". Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Renal Oncocytoma, Urinary Tract Infection in Children, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Tongco is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Renal Oncocytoma, UPJ Obstruction, Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

. Dr. Mcgoldrick is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, and Ureteroscopy.